Archives

Und theoretisch: Die #Pharmaindustrie könnte dann

Und theoretisch: Die #Pharmaindustrie könnte dann wieder #Biosimilars kreieren, die um die Fruchtbarkeit zu erhöhen… https://t.co/C2FHOngGZi

I’ve had #crohnsdisease since I was a teen. It t

I’ve had #crohnsdisease since I was a teen. It took yrs & getting very sick to get a diagnosis & treatment. Used to… https://t.co/4jddhwlKg7

Luchando por vivir 💪🏻💜 Dar visibilidad pa

Luchando por vivir 💪🏻💜
Dar visibilidad para encontrar un tratamiento que nos de calidad de vida y encontrar una cur… https://t.co/nfvgI9RAFm

­Mother of two Helen uses #biosimilars to help ba

­Mother of two Helen uses #biosimilars to help battle non-Hodgkin #lymphoma “after just two #treatments of the bios… https://t.co/bM2OHcU0f1

In March, the @BioPrescribers hosted a panel discu

In March, the @BioPrescribers hosted a panel discussion on recently proposed policies impacting access to biosimila… https://t.co/lATuvMUtJM

@jerrymacgp @Frazzling I’m unfamiliar as to whet

@jerrymacgp @Frazzling I’m unfamiliar as to whether there are studies testing the efficacy of biosimilars in situations of polyimmunity.

Communication of Regulatory Agencies in Latam: Reg

Communication of Regulatory Agencies in Latam: Regulatory trends study. With @Patricia Socualaya on June 24th. Regi… https://t.co/PDPrrnMnXE

#jl_biosimilars #latam #biosimilars #pharma #pharm

#jl_biosimilars #latam #biosimilars #pharma #pharmaceuticalindustry #healthcare #biotech #forum #jackleckermanhttps://t.co/Yd9fsq1Oc1

@HarvieTimothy @Frazzling Serious, non-confrontati

@HarvieTimothy @Frazzling Serious, non-confrontational question: is there blinded, randomized clinical trial data t… https://t.co/l9BVt4bccb